Research study of rare round cell sarcoma biology and outcomes
Part of Cancer clinical trials.
This study collects information and archived tumor samples from people with undifferentiated round cell sarcoma to better understand the disease. It may help future diagnoses and treatments by linking lab findings in tumor tissue to clinical outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or the patient’s records) have a diagnosis of undifferentiated round cell sarcoma
- There is clinical information available from your care, including outcomes (results over time)
- The study can access stored tumor tissue, like old pathology slides or preserved tumor blocks
- If you are newly diagnosed, the study plans to enroll new patients as well
- Your diagnosis cannot be a different type of cancer than undifferentiated round cell sarcoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the medical details and outcomes of people with breast sarcoma. It may help doctors better understand what treatments and factors are linked to different results over time.
This is an observational study for people diagnosed with epithelioid sarcoma, focused on how patients are followed over time. It does not appear to test a new treatment, but it can help doctors better understand the disease and follow-up needs.
This study looks at the genetic (DNA) features of tumors in children, teens, and young adults with osteosarcoma, Ewing sarcoma, or synovial sarcoma. It may help researchers better understand these cancers by analyzing a fresh tumor sample and a blood sample.
This study looks at immune system “fingerprints” using tumor tissue from people with rare soft tissue sarcoma. It may help researchers understand what drives these cancers and guide future treatments.
This study looks at tissue (samples taken during diagnosis or treatment) to learn new biological and molecular clues about soft-tissue sarcoma. Participating mainly helps researchers collect usable tissue that would otherwise be discarded.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Undifferentiated Round Cell Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.